Rezultati pretraživanja
  1. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

  2. prije 10 sati
    Odgovor korisniku/ci

    I agree, the power of randomized trials. As stated before, the data are reminiscent of N0147 where cetuximab added to FOLFOX as adjuvant tax in stage 3 colon cancer increased recurrence rate by 20%! We truly don;t know why.

  3. prije 17 sati

    On   Releases the 15th Annual Report on the Progress Against 👉 Clinical Cancer Advances 2020

  4. List... high impact research published in Oxford University Press journals which highlight prevention and risk factors of different cancers.

  5. 4. velj

    editorial New decade, new opportunities, reflects on the challenges and opportunities in oncology, highlighting 2 themes⬆️unaffordability and cost of cancer Th & opportunities with digital health and AI‼️ 🚨

  6. 3. velj

    Another insightful paper from : In p53(+) tumors, peripheral blood lymphocytes (PBLs) elicit T-cell response targeting TP53 mutations. TP53(+) PBLs can be a non-invasive source for p53 neoantigens.

  7. 3. velj

    Today is . A day to remember the lifesaving impact of and care. Everyday our teams of clinicians and researchers and provide care and advance science to save and improve lives.

  8. 3. velj

    Dear colleagues, A big Big BIG shout out📣to our amazing 🚨 & editors: Our wonderful colleagues 👩‍⚕️🇭🇷 👩‍⚕️🇧🇷& 👩‍⚕️🇵🇹. Hope you are following them, because we sure are 😃 Best, & 🌎

  9. 3. velj

    Platinum efficacy in pancreatic cancer with homologous recombination deficiency (HRD)

  10. 2. velj

    On the final leg of my journey from Oz to Milan ✈️ for Very excited for tomorrow’s sarcoma preceptorship, meeting everyone and the conference ahead!

  11. 2. velj

    Interesting thoughts from regarding TailorX + MINDACT trials:

    Prikaži ovu nit
  12. 2. velj

    Cancer-specific mortality in HIV-infected pts not entirely explained by differences in cancer treatment. There might be an association between immunosuppression &cancer control.

  13. 2. velj

    The impact of comprehensive geriatric assessment interventions on to in older people | British Journal of Cancer

  14. 1. velj
  15. 31. sij
  16. 30. sij

    I would love to set up a central collection of data from patients treated off-trial. For instance: RegoNivo in mCRC, use of ctDNA in early stage CRC. This would be highly innovative, real world data telling us what works!

  17. 30. sij

    Today in : ex-smokers have ~4X genetically healthier cells than smokers, likely helping to avoid 👉Truly never too late to stop smoking...Please tell your smoking friends.

  18. 30. sij

    Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial | NEJM lung cancer mortality significantly lower in those with volume CT screening compared to no screening

  19. 29. sij

    The Daily Tweet "Sex differences in cancer biology and treatment deserve more attention and systematic investigation.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.